Cadila Healthcare’s Biologics manufacturing facility successfully completes USFDA inspection

Deepthi | Myequity news | Date : 24-08-2018 17:30:00 IST

Cadila Healthcare Limited announced today that the USFDA inspected its Biologics manufacturing facility (Zydus Biologics) located at the Zydus Biotech Park in Ahmedabad, from 14th August to 24'h August 2018. At the end of the inspection, no observation (483) is issued.

About Zydus Cadila:

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies. The group employs nearly 23000 people worldwide and is dedicated to creating healthier communities globally. Zydus aspires to be a research—based pharmaceutical company by 2020

More from Myequity